Deborah Denno comments to the Seattle Times on how the nation’s shortage of execution drugs is becoming increasingly acute as more pharmacies conclude that supplying the lethal chemicals is not worth the bad publicity and the legal and ethical risks.
“This is not a good business model for compounding pharmacies, to be making drugs for executions, particularly with all the secret ways they’re doing it,” Fordham Law School professor Deborah Denno said.
Read the entire Seattle Times story.